Latest Insider Transactions at Amicus Therapeutics, Inc. (FOLD)
This section provides a real-time view of insider transactions for Amicus Therapeutics, Inc. (FOLD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AMICUS THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AMICUS THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 15
2021
|
Hung Do Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,458
+4.88%
|
-
|
|
Jan 15
2021
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,770
-1.81%
|
$100,170
$21.84 P/Share
|
|
Jan 15
2021
|
Daphne Quimi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,502
+3.47%
|
-
|
|
Jan 15
2021
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,794
-3.83%
|
$184,674
$21.84 P/Share
|
|
Jan 15
2021
|
Ellen Rosenberg Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,731
+8.28%
|
-
|
|
Jan 04
2021
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+3.62%
|
$34,500
$23.17 P/Share
|
|
Jan 04
2021
|
David Michael Clark Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,369
+14.8%
|
-
|
|
Jan 04
2021
|
Samantha Prout Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,533
+28.63%
|
-
|
|
Jan 04
2021
|
Bradley L Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
57,620
+13.67%
|
-
|
|
Jan 04
2021
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
10,514
-3.32%
|
$231,308
$22.17 P/Share
|
|
Jan 04
2021
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,514
+3.21%
|
$63,084
$6.45 P/Share
|
|
Jan 04
2021
|
Daphne Quimi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,131
+11.51%
|
-
|
|
Jan 04
2021
|
Hung Do Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,572
+7.68%
|
-
|
|
Jan 04
2021
|
Ellen Rosenberg Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,131
+13.7%
|
-
|
|
Jan 04
2021
|
John F Crowley Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
115,240
+11.81%
|
-
|
|
Jan 04
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,500
-1.0%
|
$165,000
$22.17 P/Share
|
|
Jan 03
2021
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,974
-4.36%
|
$321,402
$23.09 P/Share
|
|
Jan 03
2021
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,053
-2.23%
|
$116,219
$23.09 P/Share
|
|
Jan 03
2021
|
Hung Do Chief Science Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,938
-2.29%
|
$205,574
$23.09 P/Share
|
|
Jan 03
2021
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,306
-4.52%
|
$191,038
$23.09 P/Share
|
|
Jan 03
2021
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
19,994
-2.59%
|
$459,862
$23.09 P/Share
|
|
Jan 02
2021
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,974
-7.78%
|
$252,402
$23.09 P/Share
|
|
Jan 02
2021
|
Samantha Prout Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,413
-8.25%
|
$32,499
$23.09 P/Share
|
|
Jan 02
2021
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,908
-7.75%
|
$618,884
$23.09 P/Share
|
|
Jan 02
2021
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,164
-6.27%
|
$348,772
$23.09 P/Share
|
|
Jan 02
2021
|
Hung Do Chief Science Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,358
-3.55%
|
$330,234
$23.09 P/Share
|
|
Jan 02
2021
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,475
-3.4%
|
$148,925
$23.09 P/Share
|
|
Jan 02
2021
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
22,968
-2.89%
|
$528,264
$23.09 P/Share
|
|
Jan 01
2021
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
11,335
-1.4%
|
$260,705
$23.09 P/Share
|
|
Dec 31
2020
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,617
-2.15%
|
$175,191
$23.09 P/Share
|
|
Dec 31
2020
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,620
-1.07%
|
$60,260
$23.09 P/Share
|
|
Dec 31
2020
|
Hung Do Chief Science Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,340
-1.3%
|
$122,820
$23.09 P/Share
|
|
Dec 31
2020
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,751
-2.43%
|
$109,273
$23.09 P/Share
|
|
Dec 31
2020
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
16,287
-1.98%
|
$374,601
$23.09 P/Share
|
|
Dec 21
2020
|
Daphne Quimi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.01%
|
$120,000
$24.09 P/Share
|
|
Dec 21
2020
|
Daphne Quimi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.97%
|
$10,000
$2.94 P/Share
|
|
Dec 15
2020
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,760
-1.32%
|
$109,480
$23.86 P/Share
|
|
Dec 15
2020
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,828
+2.86%
|
$104,140
$5.42 P/Share
|
|
Dec 15
2020
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,156
-1.67%
|
$95,588
$23.86 P/Share
|
|
Dec 15
2020
|
Daphne Quimi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,321
+3.08%
|
$90,963
$3.33 P/Share
|
|
Dec 15
2020
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
22,000
-2.6%
|
$506,000
$23.91 P/Share
|
|
Dec 15
2020
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+2.54%
|
$132,000
$6.45 P/Share
|
|
Dec 14
2020
|
Hung Do Chief Science Officer |
SELL
Open market or private sale
|
Direct |
111,125
-21.34%
|
$2,555,875
$23.88 P/Share
|
|
Dec 01
2020
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+3.75%
|
$34,500
$23.5 P/Share
|
|
Dec 01
2020
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
24,783
-6.82%
|
$545,226
$22.77 P/Share
|
|
Dec 01
2020
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,783
+6.38%
|
$49,566
$2.52 P/Share
|
|
Dec 01
2020
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,500
-0.9%
|
$165,000
$22.77 P/Share
|
|
Dec 01
2020
|
Michael Aaron Kelly |
BUY
Grant, award, or other acquisition
|
Direct |
8,837
+50.0%
|
-
|
|
Nov 04
2020
|
Samantha Prout Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,931
-25.71%
|
$118,620
$20.0 P/Share
|
|
Nov 04
2020
|
Samantha Prout Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,931
+10.85%
|
$71,172
$12.46 P/Share
|